Home Authors Posts by Matt Wade

Matt Wade

422 POSTS 0 COMMENTS
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Bullish_Equities

Bullish run on equities grips the market

Matt Wade - 0
Market_bounce

Market Volatility takes a break (DIS, AMD)

Matt Wade - 0

SPY calls could boost today’s session

Matt Wade - 0

Markets could rebound today: SPY September 30, 300 Calls

Matt Wade - 0

The Key for Exelixis, Inc. (NASDAQ:EXEL) Could Be Very Simple

Matt Wade - 0
1...838485Page 84 of 85

Recent Post

Wave Life Sciences ($WVE) Achieves Groundbreaking Success in RNA Editing for...

Gavins Felicity - 0
In a landmark advancement in biotechnology, Wave Life Sciences Ltd. (Nasdaq: WVE), headquartered in Cambridge, Massachusetts, has announced compelling results from its...

Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments

WeightWatchers (WW stock) Embraces Compounded Semaglutide, Sending Stock Soaring

Capricor Therapeutics (CAPR) Soars on Promising FDA Discussions: Is This a...

EMCORE (EMKR): A Takeover Target? Mobix Labs’ Bold Bid Shakes Things...

© BioPharma Journal 2020